Emerald Health Therapeutics Inc

is pleased to receive the full municipal permitting for its properties in
British Columbia. It looks forward to commencing its operations at two of its
78,000 square foot greenhouses. Health Canada has been reviewing the company
and after realizing it had met the required conditions gave it the cultivation
license amendment.

A close outlook

Emerald is
currently staring at an additional license 50,000 square feet growing space,
and some other seven grow areas. At the current state of affairs, the business
guru can commence its operations at the site. In a statement, the company said
it was making plans to kickstart its planting activities at the site. If all
moves according to plan, the planting activities may reach completion by the
end of Q4.Probably, the first harvest may be in January 2020.

The Chief
Executive Officer of Emerald Riaz Bandali has spoken about the matter. He says
that they look forward to starting the planting activities. According to the
official, the Metro Vancouver organic operation will see the company move to
new financial heights.

He also
congratulated the company for its most recent achievement. He thinks that the
licensing of the Québec premium craft product indoor cultivation site is a
major step forward for them. Emerald Health Therapeutics seeks to produce
industry-leading products in terms of quality, and it will make it happen in
the Metro Vancouver site. The business giant says it will be counting on its
extensive experience in production and compliance to make it in the dynamic
markets. As always, product consumers in the market aspire to obtain premium
organic products, and this is what the company is working towards.

Other major developments

Emerald Health
Therapeutics has also spoken about the latest development regarding its
wholly-owned production facility, Verdélite. The facility obtained a license
amendment permitting from Health Canada. With this development, it seeks to
focus on the sale and distribution of packaged, branded dried cannabis
products. It will distribute the products to the authorized private retailers
and territorial wholesalers. All the products being package by Verdélite are
under the Emerald brand.

The other thing
is that Emerald Health Therapeutics has distanced itself from certain terms
reading its agreement with Pure Sunfarms Corp. It asserts that it doesn’t have
any liability in the deal. Pure Sunfarms Corp happens to be Emerald’s 50%-owned
joint venture, and the exchanges are in line with the current Supply Agreement
between the two. The company is not happy with the way the joint venture
conducted the Supply Agreement.